RDS2 Solutions

Early-stage pharmaceutical company with an international patent-pending, short-development-cycle treatment for under-treated, high-cost lung diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Stony Brook, NY, US
  • Currency USD
  • Founded December 2016
  • Employees 6
  • Incorporation Type S-corp
  • Website RDS2Solutions.com

Company Summary

RDS2 Solutions is an early-stage pharmaceutical development company with an international patent-pending, short-development-cycle treatment for under-treated, high treatment cost lung diseases.

Our product is built upon on critical combinations of FDA-approved items and our Intellectual property.

Our development is using Vasoactive Intestinal Peptide (VIP) Hyaluronan to treat pulmonary fibrosis and lung injury.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free